Not only did GM-CSF neutralization dampen CRS, but it also resulted in decreased myeloid and T-cell infiltration in the central nervous system and reduction of neuroinflammation in a patient-derived xenograft model. The gene discussed is CSF2; the disease is congenital rubella syndrome.